ES2147499B1 - Derivados de acidos carboxilicos, metodo para su elaboracion y agentes terapeuticos que contienen estos compuestos. - Google Patents
Derivados de acidos carboxilicos, metodo para su elaboracion y agentes terapeuticos que contienen estos compuestos.Info
- Publication number
- ES2147499B1 ES2147499B1 ES009702245A ES9702245A ES2147499B1 ES 2147499 B1 ES2147499 B1 ES 2147499B1 ES 009702245 A ES009702245 A ES 009702245A ES 9702245 A ES9702245 A ES 9702245A ES 2147499 B1 ES2147499 B1 ES 2147499B1
- Authority
- ES
- Spain
- Prior art keywords
- derivatives
- elaboration
- compounds
- therapeutic agents
- agents containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000002253 acid Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 229940124597 therapeutic agent Drugs 0.000 title abstract 2
- 150000007513 acids Chemical class 0.000 title 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 3
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- -1 hydroxamic acid amide Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- SKIVFJLNDNKQPD-UHFFFAOYSA-N sulfacetamide Chemical compound CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 SKIVFJLNDNKQPD-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D317/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
- C07C2602/30—Azulenes; Hydrogenated azulenes
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
Derivados de ácidos carboxílicos método para su elaboración y agentes terapéuticos que contienen estos compuestos. Los derivados están representados por sus siguientes sales: en donde R{sub,1 , R{sub,2 , R{sub,3 y A tienen los significados indicados en la memoria. El método se caracteriza porque se hace reaccionar un ácido- éster carboxílico (II) con una amina (III), seguido de la hidrólisis de la esteramida (IV) para dar la amida de ácido carboxílico (V); o bien la amida (V) se hace reaccionar con hidroxilamina, para dar amida de ácido hidroxámico (VI).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8291737A JPH10130217A (ja) | 1996-11-01 | 1996-11-01 | カルボン酸及びその誘導体及びその製造法並びにこれを含有する医薬組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2147499A1 ES2147499A1 (es) | 2000-09-01 |
ES2147499B1 true ES2147499B1 (es) | 2001-04-16 |
Family
ID=17772754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES009702245A Expired - Fee Related ES2147499B1 (es) | 1996-11-01 | 1997-10-29 | Derivados de acidos carboxilicos, metodo para su elaboracion y agentes terapeuticos que contienen estos compuestos. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5990158A (es) |
JP (1) | JPH10130217A (es) |
KR (1) | KR19980041978A (es) |
BE (1) | BE1014887A5 (es) |
DE (1) | DE19748040B4 (es) |
ES (1) | ES2147499B1 (es) |
FR (1) | FR2755438B1 (es) |
GB (1) | GB2318789B (es) |
IT (1) | IT1295936B1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0887339A1 (de) * | 1997-06-27 | 1998-12-30 | Roche Diagnostics GmbH | Neue Azulenderivate und diese enthaltende Arzneimittel |
EP0922702A1 (de) * | 1997-12-13 | 1999-06-16 | Roche Diagnostics GmbH | Neue Azulenderivate und diese enthaltende Arzneimittel |
JP2001055327A (ja) * | 1999-06-11 | 2001-02-27 | Fuji Chemical Industries Ltd | 新規なヒドロキサム酸誘導体を含む医薬 |
PE20030701A1 (es) | 2001-12-20 | 2003-08-21 | Schering Corp | Compuestos para el tratamiento de trastornos inflamatorios |
ATE457716T1 (de) | 2002-12-30 | 2010-03-15 | Angiotech Int Ag | Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung |
CN101353320A (zh) * | 2007-07-24 | 2009-01-28 | 中国人民解放军军事医学科学院毒物药物研究所 | 基质金属蛋白酶抑制剂、含有它们的药物组合物及其制备方法和用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992009565A1 (en) * | 1990-12-03 | 1992-06-11 | Celltech Limited | Peptidyl derivatives |
GB9102635D0 (en) * | 1991-02-07 | 1991-03-27 | British Bio Technology | Compounds |
US5514716A (en) * | 1994-02-25 | 1996-05-07 | Sterling Winthrop, Inc. | Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof |
-
1996
- 1996-11-01 JP JP8291737A patent/JPH10130217A/ja not_active Withdrawn
-
1997
- 1997-10-28 BE BE9700854A patent/BE1014887A5/fr not_active IP Right Cessation
- 1997-10-29 KR KR1019970056094A patent/KR19980041978A/ko not_active Application Discontinuation
- 1997-10-29 ES ES009702245A patent/ES2147499B1/es not_active Expired - Fee Related
- 1997-10-30 IT IT97MI002440A patent/IT1295936B1/it active IP Right Grant
- 1997-10-30 DE DE19748040A patent/DE19748040B4/de not_active Expired - Fee Related
- 1997-10-30 FR FR9713646A patent/FR2755438B1/fr not_active Expired - Fee Related
- 1997-11-03 GB GB9723192A patent/GB2318789B/en not_active Expired - Fee Related
- 1997-11-03 US US08/963,195 patent/US5990158A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5990158A (en) | 1999-11-23 |
FR2755438A1 (fr) | 1998-05-07 |
ES2147499A1 (es) | 2000-09-01 |
KR19980041978A (ko) | 1998-08-17 |
GB2318789B (en) | 2001-03-21 |
JPH10130217A (ja) | 1998-05-19 |
DE19748040A1 (de) | 1998-05-07 |
FR2755438B1 (fr) | 2004-08-20 |
BE1014887A5 (fr) | 2004-06-01 |
DE19748040B4 (de) | 2005-12-29 |
GB9723192D0 (en) | 1998-01-07 |
IT1295936B1 (it) | 1999-05-28 |
GB2318789A (en) | 1998-05-06 |
ITMI972440A1 (it) | 1999-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2159851T3 (es) | Amidas de acidos aminotiofenocarboxilicos y su empleo como inhibidores de la fosfodiestearasa. | |
ES2061480T3 (es) | Ariloxi- y arilaciloxi-metilcetonas inhibidoras de tiol proteasas. | |
PT99445A (pt) | Processo para preparacao de derivados do 1,4,7,10-tetraazaciclododecano mono-n--substituidos e de composicoes farmaceuticas que os contem | |
DK0783486T3 (da) | Hidtil ukendte prostaglandinsynthaseinhibitorer | |
ES464463A1 (es) | Un procedimiento para preparar derivados de acilo sustituidode aminoacidos. | |
DK94188A (da) | Maettede fedtsyreamider som inhibitorer for kolesterol-acyltransferase | |
DK0620214T3 (da) | 1H-indol-3-eddikesyrehydrazid som sPLA2-inhibitorer | |
CO4900036A1 (es) | Compuestos inhibidores de metaloproteasas de amina ciclica substituida composiciones farmaceuticas que los contienen y metodos para su utilizacion | |
PT97065A (pt) | Processo para a preparacao de 1,4,7,1o-tetraazaciclodecano-butiltrois e de composicoes farmaceuticas que os contem | |
AR004122A1 (es) | Procedimiento para la preparacion de un compuesto de dihaloazolopirimidinas y un procedimiento para la preparacion de un intermediario de dicho procedimiento | |
MX9305847A (es) | Metodo para la utilizacion de derivados de aminas como inhibidores de la corrosion. | |
DK0705257T3 (da) | Aminosyrederivater som NO-syntaseinhibitorer | |
BR9713178A (pt) | Inbidores espirocìclicos da metaloprotease. | |
SE8301008D0 (sv) | Pyrrolacetic amide having antiinflammatory activity | |
BR9712792A (pt) | Inibidores de metaloprotease bidentada. | |
DE69512589D1 (de) | Behandlung von durch Talgdrüse verursachten Erkrankungen mit Inhibitoren der Acyl CoA Cholesterin Acyltransferase | |
ES2147499B1 (es) | Derivados de acidos carboxilicos, metodo para su elaboracion y agentes terapeuticos que contienen estos compuestos. | |
AU8866882A (en) | 2-(n-hydroxycarbamoyl)phenylpropanoyl amino acids | |
ES2098570T3 (es) | Amidas de un acido 4-amino-2-ureido-pirimidina-5-carboxilico, procedimiento para su preparacion, medicamentos que contienen estos compuestos y su utilizacion. | |
PT90254A (pt) | Processo para a preparacao de amidas de acidos ciclometileno -1,2-dicarboxilicos com actividade terapeutica e de composicoes farmaceuticas que as contem | |
MX170841B (es) | Proceso mejorado para la sintesis catalizada de metacrilaminadas y acrilimidas n-substituidas | |
ES522436A0 (es) | Procedimiento analogo para preparar acido (r,s)-5-amino-hepta-5,6-dienoico,acido (s)-4-amino-hepta-5,6-dienoico o sus sales farmaceuticamente aceptables. | |
IT8148270A0 (it) | Composti di n-(cicloalchil)ammino acido utili come inibitori dell'enzima di conversione dell'angiotensi na i | |
ES2055651B1 (es) | Procedimiento para la obtencion de nuevas amidinas derivadas de 3-aminoetilindoles. | |
FR2356423A1 (fr) | Derives de l'acide thiazolidinecarboxylique, leur preparation et leur application comme medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20000901 Kind code of ref document: A1 Effective date: 20000901 |
|
FD1A | Patent lapsed |
Effective date: 20061030 |